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• Osteoarthritis (OA) is a multifactorial disease often
progressing from an initial insult or injury to whole-joint
inflammation and degeneration causing pain and
dysfunction
• Previous studies have indicated moderate to weak linear
correlations between inflammatory and degradation
related biomarker production levels by OA cartilage
during culture
• This study was designed to characterize non-linear
relationships among pro-inflammatory and degradation-
related biomarkers produced by articular cartilage
recovered from patients with knee OA
Introduction
Hypothesis
There will be significant (p<0.5) differences in the
production of inflammatory and degradative
biomarkers (Testing) when grouped based on the
production level of another biomarker (ranking)
produced by OA cartilage.
• The data from this study indicates that there are non-linear relationships between inflammatory and
degradation-related biomarker production.
• Further analysis of these production relationships between inflammation-related biomarkers and
degradation-related biomarkers produced my OA cartilage may provide insight into novel regulatory
pathways that contribute to the development and progression of OA clinically.
• Identifying these mechanistic intracellular signaling pathways and relating them to severity of OA
may allow for the identification of novel targets for therapeutic intervention for the treatment and
prevention of OA clinically
Conclusions
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Methods
2. Cartilage was separated from bone, and cartilage
explants were cultured for 3 days
3. After 3 days culture, media were collected and stored at
-20˚C for subsequent biomarker analyses and the
cartilage explant was weighed
1. With IRB approval (IRB# 1208392) and informed consent,
tissues normally discarded after total knee arthroplasty
were recovered from OA patients (n=11), and 6mm
osteochondral explants (n=359) were created
4. Media were tested for MMP-1, MMP-2, MMP-3, MMP-7,
MMP-8, MMP-13; TIMP-1, TIMP-2, TIMP-3, TIMP-4, PDGF-
AA, IL-6, IL-8, IL-10, IL-13, IL-1RA, IL-1β, FRACTALKINE
GRO-α, MCP-1, MCP-3, MIP-1α, MIP-1b, TNF-α, and
VEGF using commercially available assays.
5. The media biomarker data were standardized to the
weight of the explant for analysis. Each biomarker was
sorted lowest to highest, and placed into 4 quartiles
based on production level, approximately 25% of all
samples in each quartile. A Kruskal Wallace test with
post-hoc analysis and Bonferroni correction were used
to determine significant differences between groups
with significance (p<0.05)
cartilage
bone
• Positive Biomarker Production patterns indicate that similar factors stimulate production of the ranking and testing biomarker by the OA cartilage
• The H1 pattern (A) indicates that factors that initiate production of both biomarkers may shared, but factors that increase the production of the 
ranking biomarker do not increase the testing biomarker
• The H2 pattern (B) indicates a stronger positive relationship between biomarkers, with potentially similar factors regulating production of both
• The H3 pattern (C) indicates that factors that stimulate the highest level of production by the ranking and testing biomarker may be shared. 
Positive Biomarker Co-Production Patterns 
RANKING TESTING RANKING TESTING RANKING TESTING RANKING TESTING
Gro-α MMP-7 MMP-1 IL-8 IL-10 MMP-1 Gro-α MMP-1
IL-13 MMP-7 MMP-1 VEGF IL-10 MMP-3 Gro-α MMP-3
IL-6 MMP-2 MMP-2 IL-6 IL-10 MMP-7 Gro-α MMP-13
IL-6 MMP-1 MMP-2 MCP-1 IL-6 TIMP-2 IL-10 TIMP-2
IL-6 MMP-3 MMP-3 Gro-α MCP-1 TIMP-2 IL-10 TIMP-4
IL-6 MMP-13 MMP-3 IL-6 MCP-1 TIMP-3 IL-6 TIMP-3
IL-6 MMP-7 MMP-3 IL-8 MIP-1α MMP-1 IL-8 TIMP-1
IL-8 MMP-1 MMP-3 MCP-1 MIP-1α MMP-3 IL-8 TIMP-2
IL-8 MMP-3 MMP-3 VEGF MIP-1α MMP-13 IL-8 TIMP-3
MIP-1α MMP-7 MMP-7 IL-10 MIP-1β MMP-3 MCP-1 TIMP-2
VEGF MMP-1 MMP-13 VEGF PDGF-AA TIMP-4 MIP-1β MMP-13
VEGF MMP-2 TIMP-3 PDGF-AA VEGF TIMP-3 PDGF-AA MMP-7
VEGF MMP-3 TIMP-3 Gro-α MMP-1 MIP-1α MMP-13 MIP-1α
VEGF MMP-7 TIMP-3 IL-6 MMP-2 MIP-1α MMP-13 IL-10
VEGF MMP-13 TIMP-3 IL-8 MMP-3 MIP-1α
Gro-α TIMP-3 TIMP-3 MCP-1
TNF-α TIMP-3 TIMP-3 MCP-3
MMP-1 Gro-α TIMP-3 MIP-1β
MMP-1 IL-10 TIMP-3 TNF-α
MMP-1 IL-6 TIMP-3 VEGF
(H1) 2 3 4 > 1 (H2) 3 4 > 1 2 (H3) 4 > 1 2 3(H1) 2 3 4 > 1
Results
• The complex biomarker production 
pattern indicates neither a positive or 
negative relationship 
• The M1 pattern (A) indicates that 
factors that stimulate production of 
the ranking and testing may be 
shared, but factors that stimulate the 
highest production of the ranking 
biomarker may inhibit the production 
of the testing biomarker
RANKING TESTING
MCP-3 TIMP-1
MCP-3 TIMP-3
RANTES MMP-3
RANTES MMP-13
TNF-α MMP-7
VEGF TIMP-1
VEGF TIMP-2
VEGF TIMP-4
MMP-1 MCP-1
TIMP-2 PDGF-AA
TIMP-2 MCP-1
TIMP-2 MCP-3
TIMP-2 TNF-α
TIMP-4 PDGF-AA
TIMP-4 IL-6
TIMP-4 IL-8
TIMP-4 Gro-α
(M1) 2 3 > 1 4
Complex Biomarker Co-Production Patterns 
• Negative Biomarker Production Patterns indicate that factors that stimulate 
the ranking biomarker production may inhibit the production of the testing 
biomarker
• The L1 pattern (A) indicates that factors that stimulate the highest 
production of the ranking biomarker may inhibit the production of the 
testing biomarker
• The L2 pattern indicates that factors increase production of the ranking 
biomarker may inhibit the production of the testing biomarker
Negative Biomarker Co-Production Patterns 
RANKING TESTING RANKING TESTING
MMP-1 MCP-3 MCP-1 MMP-8
MMP-1 MIP-1β MCP-1 MMP-13
MMP-8 VEGF MCP-1 TIMP-4
TIMP-1 MCP-3 MCP-3 TIMP-4
TIMP-1 MIP-1β PDGF-AA MMP-13
TIMP-1 TNF-α PDGF-AA TIMP-1
TIMP-4 PDGF-AA TIMP-1 TIMP-4
TIMP-4 MIP-1α VEGF MMP-8
MMP-13 MCP-3
MMP-13 TNF-α
MMP-8 MCP-1
TIMP-4 MIP-1β
TIMP-4 TNF-α
(L1) 1 2 3 > 4 (L2) 1 2 > 3 4
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A
B
A
